how glp-1 drugs cause gastroparesis lawsuits Ozempic Lawsuit – July 2026 Update how glp-1 drugs cause gastroparesis

GLP-1 Therapy: Where Do We Stand in 2025

Nauck M, Weinstock RS, Umpierrez GE, Guerci B, Skrivanek Z, Milicevic Z

Injectable GLP-1 medications are administered once weekly because their half-lives are much longer than physiologic incretin hormones

In diabetes care, endocrinologists bring deep knowledge of insulin dynamics, complication management, and complex pharmacotherapy

GLP-1 RA use continues to increase among the general population, and thus, managing these patients in the perioperative setting is becoming more and more common (Chang et al

Oral semaglutide likewise resulted in reductions in weight during the trial